Decoding Developmental Epilepsies DBA International SCN8A Alliance

EIN: 471822559 501(c)(3) Diseases & Disorders

Washington, DC

Total Revenue
$586,220
Total Expenses
$310,707
Total Assets
$689,190
Net Assets
$671,299
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2019
Legal Domicile
DC
Principal Officer
Gabrielle A Conecker
Phone
2022500599
Tax Period
2023-01-01 to 2023-12-31

Decoding Developmental Epilepsies DBA International SCN8A Alliance, founded in 2019, is a small nonprofit in the Diseases & Disorders sector that reported $586K in total revenue in fiscal year 2023. Revenue decreased 7% compared to the prior year. The organization ran a surplus of $276K, a strong 47% operating margin.

Mission

WE WORK COLLABORATIVELY TO ACCELERATE THE PACE OF SCIENCE ON SCN8A AND RELATED DISORDERS IN ORDER TO BRING HOPE AND IMPROVED OUTCOMES FOR ALL THOSE LIVING WITH RARE EPILEPSIES AND THEIR FAMILIES.

Program Service Accomplishments

Program 1
Expenses: $251,552 Revenue: $192,446

RESEARCH ? SINCE 2015, THE INTERNATIONAL SCN8A ALLIANCE HAS HELPED BUILD THE CORE OF RESEARCHERS COMMITTED TO FINDING ANSWERS BY FUNDING EARLY CAREER RESEARCHERS. WITH 90% OF OUR GRANTEES STILL...

Read more

RESEARCH ? SINCE 2015, THE INTERNATIONAL SCN8A ALLIANCE HAS HELPED BUILD THE CORE OF RESEARCHERS COMMITTED TO FINDING ANSWERS BY FUNDING EARLY CAREER RESEARCHERS. WITH 90% OF OUR GRANTEES STILL FOCUSED ON SCN8A AND RELATED RESEARCH AFTER THEIR GRANTS ARE COMPLETED, THESE EARLY CAREER RESEARCHERS ARE OPENING THEIR LABS AND CONDUCTING NOVEL RESEARCH ON A RANGE OF EMERGING AND ENTRENCHED ISSUES RELATED TO SCN8A AND RARE EPILEPSIES. PLEASE SEE SCHEDULE O FOR ADDITIONAL INFORMATION ON RESEARCH ACCOMPLISHMENTS. WE ALSO HOST SCIENTIFIC MEETINGS TO ALIGN THE COMMUNITY ON CRITICAL RESEARCH EFFORTS AND TO HELP ENSURE COORDINATION AND COLLABORATION ACROSS THE GLOBE. THESE MEETINGS ARE CATALYSTS FOR NEW PARTNERSHIPS AND ADVANCING SCIENTIFIC PROGRESS IN BOTH SCN8A AND DEES.

Program 2

EDUCATION: WE WORK TO IMPROVE THE UNDERSTANDING OF SCN8A BY ENSURING THAT STAKEHOLDERS FOSTER RELATIONSHIPS BREAK DOWN BARRIERS AND COLLABORATE TO FIND TREATMENTS AND IMPROVE THE QUALITY OF LIFE FOR...

Read more

EDUCATION: WE WORK TO IMPROVE THE UNDERSTANDING OF SCN8A BY ENSURING THAT STAKEHOLDERS FOSTER RELATIONSHIPS BREAK DOWN BARRIERS AND COLLABORATE TO FIND TREATMENTS AND IMPROVE THE QUALITY OF LIFE FOR ALL. EDUCATION IS A TWO?WAY STREET. WE LEARN FROM FAMILIES AND WE PROVIDE OPPORTUNITIES FOR FAMILIES TO ENGAGE WITH RESEARCHERS PHARMA CLINICIANS REGULATORS AND BEYOND. WE PULL DOWN SILOS THAT STALL PROGRESS AND ENSURE ALL ARE WORKING WITH THE UTMOST SPEED TO REACH OUR GOAL A CURE FOR OUR CHILDREN. FOR SCN8A, WE HOST MEETUPS WEEKLY (WITH 4 LANGUAGE GROUPS) TO DISCUSS WHAT WE ARE LEARNING FROM OUR REGISTRY AND HEAR FROM FAMILIES. ACROSS THE DEVELOPMENT AND EPILEPTIC ENCEPHALOPATHIES, VIA OUR DEE?P CONNECTIONS PROJECT, WE HAVE HOSTED MORE THAN 70 INTERACTIVE WEBINARS SINCE 2020 TO BRING CRITICAL INFORMATION AND RESOURCES TO DEE CAREGIVERS.

Program 3

ADVOCACY ? OUR EFFORTS, SPANNING BOTH THE BROAD RANGE OF DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEES) AND SCN8A, INCLUDE DIVERSE ADVOCACY EFFORTS TO BOTH LEGISLATIVE AND ADMINISTRATIVE...

Read more

ADVOCACY ? OUR EFFORTS, SPANNING BOTH THE BROAD RANGE OF DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES (DEES) AND SCN8A, INCLUDE DIVERSE ADVOCACY EFFORTS TO BOTH LEGISLATIVE AND ADMINISTRATIVE POLICYMAKERS. OUR LEGISLATIVE ADVOCACY INCLUDES MULTIPLE EFFORTS ADDRESSING PENDING LEGISLATIVE ACTIONS AND APPROPRIATIONS THAT AFFECT SUPPORTED RESEARCH AND SUPPORT FOR FAMILIES (I.E., PROPOSED MEDICAID CHANGES) AS WELL AS ADVOCATING FOR ADDITIONAL FEDERAL FUNDING FOR TRANSLATIONAL EPILEPSY RESEARCH. TO ENSURE OUR COMMUNITY IS HEARD, WE HAVE ALSO PROVIDED MULTIPLE COMMENTS TO FEDERAL AGENCIES, INCLUDING THE FDA, NIH, AND CDC, OFTEN BUT NOT EXCLUSIVELY IN RESPONSE TO PUBLISHED RFIS. A SIGNIFICANT EFFORT INCLUDED A SUBMISSION OF DATA AND FAMILY STORIES FOR THE FDA TO PROVIDE REQUIRED CONTEXT ABOUT SCN8A PATIENT PERSPECTIVES, PRIORITIES, AND LIVED EXPERIENCES. ANOTHER WAS SUBSTANTIVE FEEDBACK ON FDA DRAFT GUIDANCE ON CLINICAL OUTCOME ASSESSMENTS. BOTH SUBMISSIONS WERE WELL RECEIVED.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $585,540
Program Service Revenue $0
Investment Income $0
Other Revenue $680
TOTAL REVENUE $586,220

Expense Breakdown

Grants Paid $5,900
Salaries & Benefits $139,811
Fundraising Expenses $18,516
Program Expenses $251,552
Other Expenses $164,996
TOTAL EXPENSES $310,707

Year-over-Year Comparison

2023 2022 Change
Revenue $586,220 $629,384 -0.1%
Expenses $310,707 $260,064 +0.2%
Net Income $275,513 $369,320 -0.3%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
10
Independent Members
8
Employees
5
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$111,005
Total Directors
10
$111,005
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Gabi Conecker Executive Dir. 40.00
Officer Director
$100,000 $0 $100,000
JayEtta Hecker Chairman 40.00
Officer Director
$11,005 $0 $11,005
Michael Halpern Director 1.00
Director
$0 $0 $0
Madeleine Oudin Director 1.00
Director
$0 $0 $0
Eric Wengert Director 1.00
Director
$0 $0 $0
Mohammad Nabeel Miskeenyar Director 1.00
Director
$0 $0 $0
Mandy Mills Director 1.00
Director
$0 $0 $0
Michael Hammer Director 1.00
Director
$0 $0 $0
Ariel Gibbons Director 1.00
Director
$0 $0 $0
Anne Thompson Heller Director 1.00
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $586,220 $310,707 $689,190 $275,513
2022 $629,384 $260,064 $453,877 $369,320
2021 $328,884 $218,240 $202,042 $110,644
Explore More Nonprofits
Top 100 Nonprofits in District of Columbia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare Decoding Developmental Epilepsies DBA International SCN8A Alliance with other nonprofits in District of Columbia and across the country.